I Díez de Corcuera

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
PURPOSE In the VELOUR study, aflibercept + FOLFIRI regimen resulted in improved survival in metastatic colorectal cancer (mCRC) patients who progressed after oxaliplatin. The use of aflibercept outside the clinical trial framework needs to be further assessed in terms of effectiveness and tolerability. METHODS Early access to aflibercept through a named(More)
  • 1